4
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9920 |
Evolocumab
|
Others | Others |
Evolocumab 是人源化单克隆抗体PCSK9的抑制剂。它与循环的 PCSK9 蛋白结合,使得PCSK9与 LDLR 结合受到抑制。它可用研究于高胆固醇血症以及动脉粥样硬化性心血管疾病的研究。 | |||
TP2018L |
GIP (human) acetate
GIP (human) acetate(100040-31-1 Free base) |
IGF-1R | Tyrosine Kinase/Adaptors |
GIP (human) acetate 是葡萄糖依赖性胰岛素分泌的刺激剂和胃酸分泌的弱抑制剂。 GIP (human) acetate 在脂质代谢和肥胖的发展中起着至关重要的作用。 | |||
T37589 |
GIP (3-42), human
Gastric Inhibitory Polypeptide (3-42) (human) |
IGF-1R | Tyrosine Kinase/Adaptors |
GIP (3-42), human (Gastric Inhibitory Polypeptide (3-42) (human)) 是一种多肽,可充当葡萄糖依赖性促胰岛素多肽 (GIP) 受体拮抗剂,在体内调节胰岛素分泌和 GIP 的代谢作用,可用于研究2型糖尿病。 | |||
TP1584 |
GIP (1-30) amide,human
GIP (1-30) amide (Human) |
||
GIP (1-30) amide (Human) is an insulin-dependent glucose-dependent polypeptide.The sugar-dependent insulin polypeptide (GIP) is an insulin secreting hormone, which can stimulate the secretion of insulin and reduce the occurrence of postpranal-glycemic dis |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN5845 |
Neochlorogenic acid methyl ester
5-O-Caffeoylquinic acid methyl ester,Methyl 3-caffeoylquinate,GIP (1-39) acetate(725474-97-5 Free base),Methyl neochlorogenate,新绿原酸甲酯 |
Antioxidant; HBV | Microbiology/Virology; oxidation-reduction |
Neochlorogenic acid methyl ester (5-O-Caffeoylquinic acid methyl ester) 来源于毛蒿和黑色苦莓(Aronia melanocarpa)果实。Neochlorogenic acid methyl ester 显示出抗 HBV 活性、抗氧化活性和醌还原酶活性,CD 为 6.7 μM。 |